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ABSTRACT 
The aggregation and structure of D-α-tocopheryl polyethylene glycol 
succinate micelles, TPGS-1000, an amphiphilic derivative of vitamin E, were 
characterized by scattering and spectroscopic methods, and the impact of different 
cyclodextrins (CDs) on the self-assembly studied, with the view of combining these 
two versatile pharmaceutical excipients in drug formulations. Combined SANS, DLS, 
time-resolved and steady-state fluorescence emission experiments revealed a core-
shell architecture with a high aggregation number (Nagg ~ 100) and a highly hydrated 
PEO corona (~ 11 molecules of solvent per EO unit). Micelles form gradually, with 
no sharp onset. Structural parameters and hydration of the aggregates were 
surprisingly stable with both temperature and concentration, a critical advantage for 
their use in pharmaceutical formulations. CDs were shown to affect the self-assembly 
of TPGS in different ways. While native CDs induced the precipitation of a solid 
complex (or pseudopolyrotaxane), methylated -CDs (in which OH groups on the 
repeated glucose units are substituted by methoxy groups) led to different outcomes: 
constructive (micellar expansion), destructive (micellar rupture) or no effect, 
depending on the number of substituents and whether the substitution pattern was 
regular or random on the rims of the macrocycle. Time-resolved SANS studies on 
mixtures of TPGS with regularly dimethylated -CD (DIMEB), which ruptures the 
micelles, revealed an almost instantaneous de-micellisation process (< 100 ms), and 
 showed that the process involved the formation of large aggregates, whose size 
evolved over time. Micellar rupture is caused by the formation of a TPGS-DIMEB 
inclusion complex, involving the incorporation of up to three macrocycles on the 
tocopherol, as shown by 1H and ROESY NMR. Analysis of NMR data using Hill’s 
equation revealed that complex formation is rather cooperative, the threading of a CD 
favoring the subsequent inclusion of additional CDs on the aliphatic moiety.  
 
INTRODUCTION 
D-α-tocopheryl polyethylene glycol succinate, TPGS, is a water soluble derivative 
of the natural form of vitamin E, produced by the esterification of the crystalline D-α-
tocopheryl succinate with polyethylene glycol (SI, Scheme 1). The presence of the PEG 
chain bestows tocopherol with an amphiphilic character and self-aggregation 
capability1, with the known advantages that non-ionic amphiphiles have over cationic 
and anionic surfactants, in terms of their low sensitivity to electrolytes, good chemical 
stability and generally better acceptability. TPGS has been extensively investigated for 
its solubilizing capacity in drug delivery2–4 and approved by the FDA. Most studies in 
the literature have used TPGS-1000, which comprises 23 EO units, and a number of 
drug formulations based on this amphiphile have been developed, including micelles5,6, 
microparticles7, nanoparticles8 and microemulsifying systems9, where TPGS is used as a 
solubilizer, absorption enhancer and a drug-carrier10,11, especially for poorly water-
soluble drugs. Many of these studies have focused on the delivery of anticancer drugs12, 
since TPGS inhibits the activity of P-glycoproteins transporters (P-gp), which is 
responsible for the poor permeability of many cancer drugs through physiological 
barriers13. Its pharmacological response has also been studied and compared to that 
obtained with other excipients14,15. 
Another class of nano-carriers widely used in pharmaceutical formulations are 
cyclodextrins (CDs), oligosaccharides formed by the association of several 
glucopyranose units in a toroid-like arrangement. The three native CDs, α, β and γ-CD, 
comprise 6, 7 and 8 glucose units in the macrocycle, respectively. The cavity, larger as 
the number of glucose residues increases, has a relatively hydrophobic character, and is 
thus capable of lodging a guest molecule, while the outer part of the CD, formed by the 
primary and secondary hydroxyl groups, is hydrophilic. These hydroxyl groups are 
susceptible of chemical substitution, improving the properties of native CDs, such as 
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their solubility or affinity for specific guests. The capacity of trapping molecules in their 
apolar cavity makes CDs useful in a range of areas, in food as a protectant and to 
encapsulate flavours and perfumes16, and in the pharmaceutical industry to solubilize 
drugs17–21. Moving beyond the small hydrophobic molecular guests, interesting 
supramolecular structures can be formed by the association of cyclodextrins with 
amphiphilic molecules (surfactants) or larger guests, such as polymers, which open up 
news prospects for the delivery of active substances21–24. For instance, the threading of 
several cyclodextrins on a polymer chain can offer multi-fold binding, if modified with 
a suitable ligand25–27, or be transported within a polyrotaxane structure (by the 
introduction of suitable stopper-groups) for release at specific sites28. The formation of 
such structures dramatically depends on the type of CD. While native CDs tend to 
produce solid adducts or precipitates, which have been explored for the production of 
injectable gels29, modified CDs tend to form soluble pseudopolyrotaxanes30,31. The use 
of these supramolecular structures for gene and drug delivery has been recently 
reviewed32. The combined use of CDs or their complexes with surfactants in a 
multifunctional approach requires the compatibility of all compounds involved in the 
complex. For pharmaceutical formulations in particular, the presence of non-controlled 
interactions or competition between the different components, could dramatically affect 
the efficacy of drug encapsulation and drug delivery, hence the necessity to carefully 
characterise structures and interactions in cyclodextrin-based multi-compartmented 
delivery systems. 
Within this framework, this investigation has two objectives. In the first step, we 
fully characterize the aggregation behavior of TPGS 1000 and its micellar structures, 
through the combined use of spectroscopic (UV-visible, fluorescence and NMR) and 
scattering techniques (SANS and DLS). In a second step, we explore the impact of both 
native and substituted cyclodextrins on the self-association of TPGS to assess the 
combined use of these excipients as drug carriers, a topic that has not been addressed 
yet in the literature. We have focused in particular on the dimethylated derivative of 
βCD, heptakis(2,6-di-O-methyl)-β-cyclodextrin (DIMEB), which is known to have an 
important disaggregating impact on non-ionic30,33 surfactants and, due to its well-
defined rim substitution, enables a detailed structural characterization of the complexes 
formed, thus helping understand the behavior of other substituted CDs. 
 
MATERIALS AND METHODS 
 Materials. Native cyclodextrins: α-cyclodextrin (≥98%); β-cyclodextrin (≥97%); γ-
cyclodextrin (≥98%) (with water contents of 10%, 14% and 10%, respectively, as 
determined by TGA) were obtained from Sigma-Aldrich. Substituted cyclodextrins: 
heptakis(2,6-di-O-methyl)-β-cyclodextrin (DIMEB, Sigma, 98%), heptakis(2,3,6-tri-O-
methyl)-β-cyclodextrin (TRIMEB, 90%), (2-hydroxyethyl)-β-cyclodextrin (HEBCD, 
0.7 molar substitution), (2-hydroxypropyl)-β-cyclodextrin (HPBCD, 0.8 molar 
substitution), (2-hydroxypropyl)-γ-cyclodextrin (HPGCD, 0.6 molar substitution), and 
randomly methylated β-cyclodextrin (RAMEB, 1.6−2.0 moles of CH3 per glucose unit) 
were all obtained from Sigma-Aldrich. The repeating units of each CD are available as 
Supporting Information (Scheme 2). D-α-tocopheryl polyethylene glycol succinate 
(TPGS) was a gift from Antares Health Products Inc, with a PEG molecular weight of 
1000 (23 EO units). All the concentrations are expressed in weight percentage, unless 
otherwise stated. 
Electronic molecular absorption and emission studies. UV-Vis absorption spectra were 
recorded on an 8453 UV-Vis Diode Array System spectrophotometer (200 nm to 800 
nm), using 1 cm path-length quartz cuvettes. Emission spectra and fluorescence 
lifetimes were measured with a FLS920 spectrofluorimeter (Edinburgh Instruments), in 
1 cm path-length quartz cuvettes. A 500 W xenon lamp was used as the source for the 
steady state fluorescence experiments, while for the time resolved experiments the 
source was switched to a 300 nm pulsed diode, triggered with a PDL 800-D pulse 
generator (PicoQuant). Data collection was stopped after 1000 counts on the detector to 
build the fluorescence decay curves. Curve fitting to obtain the fluorescence lifetimes 
was performed with FAST software (Edinburgh Instruments Ltd.), by deconvolution 
with the scattering decay of a diluted Ludox® solution. 
NMR spectroscopy. A Bruker Advance 400 MHz spectrometer was used for recording 
all the monodimensional 1H-NMR and 1H-COSY spectra. 2D-ROESY experiments 
were performed with a Bruker AVIII 700, at 700 MHz. Deuterated solvents used were 
DMSO (deuterium content > 99%), for signal assignation of TPGS and analysis of the 
compositions of the solid complexes, and D2O (≥99.85% in deuterated component) for 
the 1D and 2D studies of the complexes with DIMEB. 
Small-Angle Neutron Scattering (SANS). Static small-angle neutron scattering (SANS) 
experiments were carried out on LOQ instrument at ISIS spallation neutron source (ISIS, 
Rutherford-Appleton Laboratory, STFC, Didcot, Oxford). LOQ uses incident 
wavelengths from 2.2 to 10.0 Å, sorted by time-of-flight, with a fixed sample-detector 
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distance of 4.1 m, which provides a range of scattering vectors, q, from 0.009 to 0.29 Å-
1. The samples were prepared in D2O (Aldrich, > 99.9% in D) and placed in clean disc-
shaped quartz cells (Hellma) of either 1 or 2 mm path length, controlling the 
temperature with an external thermostat. All scattering data were first normalized for 
sample transmission and then background-corrected using a quartz cell filled with D2O 
to compensate for inherent instrumental background, and finally corrected for linearity 
and efficiency of the detector response using instrument-specific software package. The 
data were then converted to differential scattering cross-sections expressed in absolute 
units of cm-1 using standard procedures at ISIS. 
SANS data analysis was performed with SasView 3.1.0 software34. Scattering 
curves from the micelles were fitted to a core-shell sphere (CSS) model combined with 
a hard-sphere (HS) structure factor. In the data analysis, the polydispersity was left free, 
as well as the scattering length density (sld) of the core and shell. The number of water 
molecules in the hydrophilic corona can be estimated from the fitted value of the sld of 
the shell, shell (a weighted average between the sld of pure PEO and D2O), and micellar 
dimensions returned by the fits. The volume fraction of solvent in the corona, xsolv is 
related to shell, EO and 𝜌𝐷2𝑂by: 
 𝑥𝑠𝑜𝑙𝑣 =
𝜌𝑠ℎ𝑒𝑙𝑙−𝜌𝐸𝑂 
𝜌𝐷2𝑂−𝜌𝐸𝑂
  Eq. 1 
The number of water molecules, nsolv, in the shell is calculated from: 
 𝑛𝑠𝑜𝑙𝑣 = 𝑥𝑠𝑜𝑙𝑣
𝑣𝑠ℎ𝑒𝑙𝑙
𝑣𝐷2𝑂
 Eq. 2 
where 𝑣𝐷2𝑂 is the volume of a molecule of solvent. The number of water molecules per 
EO group, nsolv/EO, can then be calculated from Eq. 2 and the aggregation number, Nagg, 
obtained from the hydration of the shell and the structural parameters of the core-shell 
model. Provided that the amount of water inside the core is negligible, the volume of the 
micelle is: 
 𝑣𝑚 = 𝑁𝑎𝑔𝑔𝑣𝑠 + 𝑥𝑠𝑜𝑙𝑣𝑣𝑠ℎ𝑒𝑙𝑙  Eq. 3 
where vs is the volume of a surfactant molecule (462 cm
3mol-1, from the manufacturer’s 
specifications). Nagg is obtained by introducing into the equation the volume fraction of 
solvent in the shell, xsolv, from Eq. 1.  
 Time-Resolved SANS (TR-SANS). Kinetic SANS measurements were carried out on D22 
at the ILL, combined with a stopped-flow unit, which allows for rapid mixing of several 
solutions and triggers the reaction with data acquisition, with acquisition times of the 
order of 100 ms.35 The wavelength λ was set at 6 Å, the peak flux of the cold source. 
The sample-to-detector distance was 4 m, with a collimation at 5.6 m and a detector 
offset of 400 mm to maximize the available q range (1.2 ·10-2 < q < 0.26 Å-1). A 7×10 
mm2 sample aperture was used, and the sample path length in the Biologic SFM-300 
stopped-flow apparatus was 1 mm and the temperature was set to 40ºC. Raw data were 
corrected for electronic background and empty cell and normalized by water using the 
proprietary Lamp ILL software (Large Array Manipulation) developed for SANS data 
treatment36. The scattering measurements were made with an acquisition time for each 
frame n of tn following a geometric series with 
 𝑡𝑛 = 𝑎
𝑛−1𝑡1     and     𝑇𝑛 =
1−𝑎𝑛
1−𝑎
𝑡1 Eq. 4 
Tn is the accumulated time after mixing, with t1 = 100 ms and a = 1.1. Sixty eight frames 
were measured for a total time of 653 s, after which 20 additional frames were measured 
with 6 s of exposure each. The average time after mixing TAMn for the n
th run is 
 𝑇𝐴𝑀1 =
𝑡1
2
+ 𝑡𝐷𝑇      and    𝑇𝐴𝑀𝑛 =
𝑇𝑛−1+𝑇𝑛
2
 Eq. 5 
tDT being the dead time needed to fill the cell, estimated at 70 ms for the flow rate used. 
The stock solutions of TPGS and CD were prepared by weighing the required amounts 
of surfactant, DIMEB and deuterated water. Appropriate volumes of stock solutions 
(total of 250 μL) were then mixed in the stopped-flow cell at a flow rate of 3 mL/s to 
obtain the target concentrations. Datasets of the experiments can be found on the ILL 
website37.  
Dynamic light scattering (DLS). Size distributions of TPGS in water and mixtures with 
substituted CDs were obtained with a photon correlation spectrometer (Malvern 
Zetasizer Nano) with a laser wavelength of 633 nm. The samples were filtered prior to 
the measurements by 0.22 m Millex syringe PVDF filters onto semi-micro glass cells, 
and the temperature controlled with 0.1˚C accuracy by the built-in Peltier in the cell 
compartment. The viscosity and refractive index of the solvent at different temperatures 
were taken into account to obtain the particle size distribution from the analysis of the 
autocorrelation function, which was performed with the Zetasizer software in the high 
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resolution mode to better distinguish overlapping distributions. The diffusion 
coefficients of TPGS as a function of concentration were obtained on a DynaPro-MS/X 
photon correlation spectrometer (90º optics, 822 nm diode laser). The experiments were 
performed at 25.0 and 50.0ºC (0.1˚C accuracy). Samples were filtered by 0.02 m filters 
(Whatman Anotop). The intensity size distributions were obtained by regularization 
analysis with Dynamics 6.0 software.  
 
RESULTS AND DISCUSSION 
Micellisation process of TPGS 
The aromatic moiety of tocopherol accounts for the UV-vis absorption of the 
molecule, with a maximum at  = 285 nm. The molar absorptivity at max, ε, can be 
obtained by a linear fit to the Beer-Lambert law, resulting in (1.86 ± 0.04) 103 M-1cm-1 
(SI, Figure S1). The low molar absorptivity of TPGS prevents a reliable estimation of 
the cmc by this technique, which can be overcome by using the emission fluorescence. 
Figure 1A shows TPGS emission spectra from 295 nm to 440 nm at λex = 285 nm over a 
range of concentrations up to 0.04%. At this excitation wavelength, Raman scattering 
due to OH stretching bands from the solvent partially overlaps with the fluorescence, 
and was thus subtracted from the spectra. The fluorescence intensity at max = 314 nm 
against concentration increases smoothly (Figure 1B), with no sharp change of slope 
marking the onset of aggregation. As an approximation, if aggregation modes such as 
fusion of small micelles is discarded, the micellization can be described by the 
equilibrium 𝑁𝑆𝑆𝑁 , where S is the surfactant and SN the micelles of aggregation 
number N. The concentration of free surfactant and micelles is related to the 
thermodynamic constant through the mass action law: 𝐾 = [𝑆𝑁]/ [𝑆]
𝑁. The presence of 
a power N makes it convenient to represent TPGS concentration on a log scale, as 
shown in Figure 1B. The inflexion point then corresponds to the concentration at which 
the change in fluorescence is steepest and can be taken as a critical concentration. A 
sigmoidal fit to the plot gives a cmc of 0.020 ± 0.005 %, obtained from three replicates, 
in good agreement with literature results obtained with pyrene fluorescence1,4. 
Further insight into the micellisation process is obtained from fluorescence 
lifetime spectroscopy. If there are different emitting species, the fluorescence decay 
upon an excitation pulse is given by: 
  𝐼𝐹(𝑡) = 𝐴 + ∑ 𝐵𝑖e
−t/𝜏𝑖 Eq. 6 
where Bi is an amplitude factor related to the intrinsic quantum yield of fluorescence 
and concentration of the i species, i its fluorescence lifetime and A the background. 
Two exponentials were used to fit the data (SI, Table T1). The fluorescence lifetime of 
vitamin E has been reported38 as 0.5 ns, therefore the fast decay corresponds to the 
monomeric form, while the second contribution, at ca. 2.2 ns, is ascribed to the 
micellised surfactant. The micellar fraction can be deduced from the ratio of the pre-
exponential factors, Fmic/FT (SI, Table T1); its value increases steadily over time, 
without a clear break-point, confirming the gradual formation of micelles rather than 
their sudden onset. 
 
TPGS micellar structure  
Dynamic Light Scattering (DLS) measurements of a 1% TPGS solution (well 
above the cmc) show a monomodal, narrow size distribution, corresponding to a 
radius of about 5 nm (Figure 2A). The diffusion coefficient, D, as a function of the 
concentration was measured at two temperatures (SI, Figure S2). The intercept of a 
linear fit to the experimental data gives the diffusion coefficient at infinite dilution 
(D0), from which the hydrodynamic radius, Rh
0, of the micelles can be deduced from 
the Stokes-Einstein equation for spheres: 
 
 𝑅ℎ
0 =
kBT
6πηD0
 Eq. 7 
 
where kB is the Boltzmann constant, T the absolute temperature and η the solvent 
viscosity at the experimental temperature. The diffusion coefficients at infinite 
dilution obtained are: (4.8 ± 0.2)×10-7 cm2s-1 at 25ºC and (8.4 ± 0.6)×10-7 cm2s-1 at 
50ºC, which correspond to an Rh
0 of  5.1 nm and 5.0 nm, respectively, showing 
negligible sensitivity to temperature, while the weak slope suggests a constant size 
over a wide range of concentrations. From these values, a rough estimation of the 
aggregation number (Nagg) is obtained by dividing the volume of a sphere of radius 
Rh
0 by the molar volume of the monomer. With a density of 1.06 g cm-3 for TPGS 
(value at 45ºC, from the manufacturer), Nagg is ca. 200, a value most likely 
overestimated since the corona must be largely hydrated. 
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SANS measurements were carried out to achieve a more detailed description of 
the micelles. As an example, Figure 2 shows the scattering of a 1% TPGS solution in 
D2O at 20ºC. Fits of the data to a CSS-HS model converge towards small core values, 
of the order of 110-7 Å-2, indicating a rather dehydrated core. The resulting 
polydispersities were of the order 0.15-0.2, in agreement with the values obtained by 
DLS. The hydration of the shell and the aggregation number, Nagg, were obtained 
from the dimensions of the micelle and fitted sld of the shell (cf Experimental 
Section).  
 
Table 1. Structural parameters of TPGS micelles extracted from SANS data analysis: Rc (core 
radius), t (shell thickness),  (volume fraction), shell (scattering length density of the shell), Nagg 
(aggregation number), nsol/EO (number of solvent molecules per EO unit in the shell). 
 Rc / Å t / Å  shell  106 / Å-2 Nagg nsol/ EO 
1%, 20ºC 37.7± 0.9 26 ± 2 0.029 6.19 ± 0.09 105 11.5 
1%, 40ºC 37.7± 0.8 25 ± 2 0.027 6.13 ± 0.09 109 10.6 
5%, 20ºC 37.0 ± 0.2 26.5 ± 0.2 0.131 6.09 ± 0.02 106 11.2 
5%, 40ºC 37.5 ± 0.2 23.9 ± 0.2 0.115 6.09 ± 0.02 108 9.6 
 
TPGS have an overall radius of ca. 63 Å, about 10 Å larger than the 
hydrodynamic radius obtained from DLS extrapolated to zero concentration (Figure 
2). Temperature has a limited effect on micellar structure (Table 1). The hydration of 
the shell (10-12 solvent molecules per EO unit, equivalent to 96% of D2O in volume) 
suggests an extensively hydrated shell, which slightly reduces with temperature, 
accompanied by a slight shrinking of the shell. This high solvent penetration is usual 
with non-ionic surfactants based on EO units; 30,31,39 for instance, X-shaped PEO-PPO 
block copolymer Tetronic 904, with 15 EOs per arm, has 6-12 solvent molecules per 
EO unit in the shell30. The relatively high aggregation numbers suggest that the 
tocopherol moieties are closely packed in the micellar core. However, the core radius, 
Rc, at ca. 37 Å, is slightly larger than the length of a fully extended tocopherol-
succinate molecule (ca. 30 Å), thus suggesting the absence of interdigitation of the 
hydrophobic tails. The Nagg reported here are substantially higher than the value of 10 
reported by Sadoqi et al.1 measured by the static quenching of pyrene fluorescence 
with N,N-dibutylaniline DBA, a value that seems quite low considering the size of the 
 micelles and the high hydrophobicity of the tocopherol moiety. As for the effect of 
concentration, micelles at 1% or 5% have virtually the same aggregation number, size, 
and number of solvent molecules per EO in the shell. Overall, it can be concluded that 
the structure of TPGS micelles is very stable with both concentration and temperature, 
an interesting point to consider for applications of TPGS as a drug carrier. In the next 
section we turn to the effect of cyclodextrins on the self-assembly structures of TPGS. 
 
Effect of cyclodextrins on TPGS aggregation 
The addition of native cyclodextrins, ,  or CD, well below their solubility 
limit, to a 1% TPGS solution leads to the formation of, first, turbid solutions, then 
white precipitates. In the case of 1% CD, the haziness is less pronounced, and DLS 
analysis reveals a size distribution similar to TPGS micelles (ca. 5 nm), together with 
a large distribution at the nominal diameter of the filter pore used (0.2 m), most 
likely due to the self-aggregation which is known to occur in native CDs40 (SI, Figure 
S3). The precipitates originate from pseudopolyrotaxane formation by threading of 
the CDs on the PEO blocks of the surfactant and further stabilization by hydrogen 
bonding between adjacent CD41. The binding of CDs to polymers based on EO units 
is rather selective, CD being the macrocycle with most affinity to PEO42. The yield 
of the complexation obtained by weighing the dried precipitate after centrifugation are 
35, 47 and 54%, for ,  and CD, respectively. The CD/TPGS molar ratio in the 
complexes (analyzed by NMR after redissolution of the precipitates) follow the same 
trend: 3.8, 5.7 and 6.2 for ,  and CD, respectively. The fact that CD produces the 
lowest yield and CD/TPGS ratio is a consequence of its narrow cavity, which only 
enables it to thread onto the PEO chain, while the wider  and CD are expected to 
also complex with the tocopherol moiety. 
Substitution of some or all of the hydroxyl groups on the macrocycles can affect 
the complexation capability quite dramatically. Modified CDs have been shown in 
particular to induce a de-micellisation process, either with Pluronics43–45, Tetronics, or 
wormlike micelles46, hence a similar behavior may be expected with TPGS. Figure 
2A shows the effect of adding dimethylated -cyclodextrin (DIMEB) to a dilute 
TPGS solution at 20ºC from DLS data. At low DIMEB concentration (1%), micelles 
are still present, but with 5% DIMEB, the micellar peak disappears, while a lower 
peak (Rh ~ 2 nm) appears, ascribed to the TPGS-DIMEB complex, and large and 
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polydisperse aggregates (ranging from a few nanometers to almost 100 nm) appear 
(whose contribution either in mass or volume must be very small). Thus, complete 
break-up of the micelles takes place above a critical amount of CD. The same 
scenario is observed at higher temperature (40ºC), with micelles remaining intact at 
1% DIMEB and disappearing with 5% DIMEB. The effect of DIMEB at different 
temperatures is corroborated by SANS analysis (Figure 3). The scattering from the 
complex was modeled by a simple monodisperse Gaussian coil (Figure 3, solid lines), 
resulting in a Rg of 12.6 Å (20ºC) and 12.7 Å (40ºC). Both values are in fair 
agreement with the hydrodynamic radii obtained by DLS of 1.8 and 1.9 nm at both 
temperatures (Figure 2A), considering Rg
2 = 3/5 Rh
2 for a hydrodynamic sphere. The 
slight increase of intensity at very low q (Figure 3) suggests the presence of larger 
size objects, which may result from further association of the complexes. 
The nature of the modified groups on the macrocycle, as well as the extent and 
regularity of the substitution can have a substantial impact on the complexation, as 
reported before43,46. For instance, the permethylated βCD (TRIMEB), which has all 
three hydroxyl groups substituted rather than two, does not affect TPGS micelles at 
5%, either at 20 or 40ºC (data not shown). The case of RAMEB, a randomly 
methylated CD, produces the exact opposite effect, as it induces the association of 
TPGS micelles into large and polydisperse aggregates of ca. 28 nm radius. These 
aggregates increase in size while becoming more monodisperse with temperature (42, 
43, and 49 nm in radius, at 30, 40, and 50ºC, respectively) (Figure 2B). This randomly 
substituted CD has been reported to act as a micelle expander of a poloxamer at high 
concentrations, a property that was then exploited to produce mesoporous γ-alumina47. 
The authors suggested that RAMEB would be located in the outer shell of the 
poloxamer micelles, interacting with the PEO segments. A similar effect with TPGS 
could explain the observed micellar growth, given the identical nature of the 
hydrophilic corona. Other substituted CD, hydroxyethyl or -propyl-βCD (HEBCD 
and HPBCD) do not impact the micelles at 1%, while HPGCD, with a larger cavity, 
does not have any effect either, at concentrations up to 5% (at either 20ºC or 40ºC). 
The above results evidence that not only the nature but also the extent and the 
regularity of the chemical substituents along the CD rim are paramount in dictating 
the final outcome of complexation: either destructive (micellar break-up) or 
constructive (micellar expansion). While native CDs produce solid 
 pseudopolyrotaxanes, regularly methylated βCD (DIMEB), with a lower capacity of 
hydrogen-bond formation between adjacent macrocycles, has a strong disruptive 
effect on TPGS micelles. Instead, thrice-methylated TRIMEB has no detectable effect 
at the same concentration, while the randomly substituted RAMEB induces micellar 
association into large aggregates. In the following, we narrow down the focus on 
DIMEB, since it is the macrocycle with the most drastic effect on TPGS micelles, a 
factor of importance if we envisage the concomitant use of CD and TPGS in a drug 
delivery system. 
 
TPGS micellar rupture induced by DIMEB  
Changes in the aggregation behavior of TPGS are likely to be reflected by 
variations in the UV absorbance or fluorescence spectra, arising either from its self-
association or the formation of a CD-TPGS inclusion complex. Below the cmc 
(0.01% TPGS), the addition of 3% DIMEB does not affect max (285 nm) in UV 
absorbance, but slight differences in the shape of the band are observed, which are 
more noticeable in the fluorescence excitation spectrum (Figure 4A, shown in a 
normalized scale for comparison purposes). In the fluorescence emission spectrum 
(Figure 4B) an enhancement of the fluorescence and a blue-shift of em, from 314 to 
303 nm, are observed. This evidence reflects changes in the micropolarity of the 
aromatic moiety of tocopherol, due to the presence of the macrocycle. 
Fluorescence decays obtained from fluorescence lifetime spectroscopy on the 
same solutions were fitted with two exponential decays, with lifetimes 1 =0.303 ± 
0.002 ns and 2 = 2.25 ± 0.04 ns and respective contributions of 98% and 2% (SI, 
Figure S5). 1 is slightly lower than the lifetime of TPGS monomers (0.4 ns, SI, Table 
T1), thus most likely corresponds to the complex with DIMEB, while the second 
decay 2 can be ascribed to micellised TPGS. It is clear that the addition of DIMEB 
drastically reduces the micellised fraction, compared to TPGS alone (SI, Table T1).  
Next, we employed time-resolved SANS (TR-SANS) to investigate the kinetics 
of de-micellization induced by DIMEB. A stopped-flow device was used to rapidly 
mix stock solutions of TPGS and DIMEB, achieving a final concentration of 1% 
surfactant and 3% DIMEB (Figure 5). The first frame is measured ca. 100 ms after 
mixing, and by this time the micelles have largely disappeared (as inferred by the 
drop in intensity), while the uprising curve at low q denotes the presence of large 
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aggregates. The drop in intensity is reminiscent of the micellar break-up obtained with 
1% TPGS and 5% DIMEB (Figure 3), while the formation of larger structures is more 
pronounced at this lower CD concentration of 3%. DLS measurements in D2O also 
confirm the presence of these large aggregates, which seem to be critically dependent 
on CD/TPGS ratio (SI, Figure S4A). Indeed, at 3% DIMEB the solution is slightly 
turbid and stable over time, while it is transparent at 5%.   
The kinetics of micellisation from scattering techniques has been recently 
reviewed by Lund et al, with a focus on block copolymer micelles48. For low 
molecular weight micelles, the process can be well described by Aniansson and Wall 
theory49, developed for near-equilibrium relaxation kinetics in terms of the rate 
constants of incorporation of a unimer into a micelle and its dissociation. For example, 
studies by gradient NMR of Pluronic P8550 (which has a similar aggregation number 
than TPGS) indicated a fast exchange between free and micellized P85 molecules, 
with a lifetime of the surfactant in the micelles between 1 s and 3 ms. T-jump 
studies on the micellar kinetics of Pluronics F127, F88 and P123 revealed a single 
relaxation time in the millisecond range, which was attributed to the exchange 
process51. Zana et al. investigated Pluronic L64 by ultrasonic absorption and T-jump 
methods, concluding that the exchange process takes place on the microsecond 
timescale and that there is essentially no energy barrier to the incorporation of a free 
unimer into the surfactant micelles upon collision, as the PPO block does not differ 
much in nature from the PEO shell that surrounds the Pluronic core52. The behavior of 
TPGS should not be very different from that of Pluronics, as the unimer has to cross a 
highly hydrated corona, to incorporate or leave the micelles. Regarding the kinetics of 
inclusion complex formation with CDs, the reaction can take place over a wide span 
of timescales, depending on the guest, but for small guests it is usually of the order of 
microseconds. As an example, a study by ultrasonic relaxation on a homologue series 
of carboxylic acids showed that the rate constants for the inclusion of pentanoic acid 
into -CD and its removal from the cavity were 7.3108 mol-1·dm3·s-1 and 0.89107 s-
1, respectively, the geometrical fit of the guest molecule within the cavity being a key 
factor to control the reaction rate53. 
To gain some insight into the CD-triggered de-micellization process from TR-
SANS, we propose here a simple model in which the overall scattering is split up 
between two contributions: one due to the large aggregates, considered as spherical, 
 with a sld equivalent to that of a micelle (calculated as 4.710-6 Å-2, from the results 
shown in Table 1) and another one due to the TPGS-DIMEB complex, which is 
modelled as a small sphere of sld equivalent to one TPGS molecule and three DIMEB, 
at 8.410-7 Å-2 (this specific stoichiometry is justified further down). The system is 
therefore modelled as a binary mixture of hard-spheres, which includes a hard sphere 
interaction between all the particles54. Figure 6 shows some of the most relevant 
findings obtained with this model. 
Consideration of these plots leads to several conclusions. First, the TPGS-
DIMEB complex has a constant size (R  25 Å) (Figure 6C) and volume fraction 
(Figure 6D), matching reasonably well the size obtained by DLS or SANS, and 
confirms that the complex is totally formed after ca. 100 ms. Second, the kinetic data 
reveal the presence of large aggregates, whose size and fraction evolve over time 
(Figure 6A and B). At 100 ms, their size (at 60 Å) is close to the size of micelles 
(Figure 6A), and their volume fraction (about 0.006, Figure 6B) has dropped 
considerably compared to a 1% TPGS solution (0.027, Table 1), but shows that 
micelles are still present in the early stages of the complexation. After a few seconds, 
the aggregates increase in size (reaching a maximum of ca. 180 Å after 10 s), while 
their volume fraction decreases (down to 0.002). While the precise composition (or 
structure) of these aggregates is unknown, they should comprise a mixture of TPGS 
and DIMEB. At sufficiently long times, these aggregates remain in solution (at least 
at 3%), while at higher DIMEB concentrations (5%), their volume contribution 
becomes negligible (SI, Figure S4B). Overall, the kinetics of micellar disruption by 
CD are extremely fast, with a near-instantaneous disappearance of the micelles and 
the formation of TPGS-CD complexes in less than 100 ms. TR-SANS also reveal that 
micellar rupture is accompanied, rather surprisingly, by the formation of large, 
indiscriminate aggregates (at this intermediate DIMEB concentration of 3%), whose 
size and volume fraction evolve over time, although their contribution by volume or 
mass remains rather small. 
 
Topology of the TPGS-DIMEB complex  
More details on the structure of the inclusion complex, i.e. its stoichiometry and 
the location of the CDs on the amphiphile, were obtained from NMR. The first 
question to address is whether the macrocycle is threaded through the surfactant 
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headgroup (PEO block) or the hydrophobic tail (tocopherol moiety); for this purpose, 
we have focused on protons from both molecules that may undergo changes in their 
positions. Signal assignation of the DIMEB protons has been reported elsewhere33, 
while that of TPGS in DMSO was carried out with the aid of the corresponding 1D 
and COSY spectrum (SI, Figure S6). 
Figure 7 presents the spectra obtained from TPGS/DIMEB mixtures at varying 
ratios, showing the aliphatic region of TPGS. Noticeable changes in the d and e 
protons of TPGS (directly bonded to the aromatic ring) occur with increasing DIMEB 
fraction, with an increase in the signals at 2.0 and 2.2 ppm, accompanied by a 
reduction and vanishing of signals at 1.8 and 1.9 ppm. The aliphatic zone between 1.0 
and 1.5 ppm, corresponding to the resonances of CH3(a) and CH2(b), shows a broad 
overlap that is difficult to track, but new signals at 1.25 and 1.35 ppm appear, along 
with the concomitant reduction of the ones at 1.0 and 1.1. In contrast, the resonance at 
3.64 ppm (data not shown), due to the EO residues, does not change, even at high 
concentrations of DIMEB. Protons H(3) and H(5) from DIMEB (which point towards 
the center of the cavity and are typically used to confirm the formation of an inclusion 
complex), are shifted upfield by about 0.1 ppm and become broader (SI, Figure S7), 
while a much smaller shift (of about 0.03), is detected in the external H(1) protons, 
which appear in a zone free of overlap (SI, Figure S7), unlike H(2) or H(4). All these 
observations confirm the formation of a TPGS-DIMEB inclusion complex, and 
indicate that DIMEB is localized on the tocopheryl moiety, and not on the PEO chain. 
It is worth mentioning that signal splitting, rather than shifting, occurs with the 
surfactant protons, but not with those from the macrocycle. This behavior can be 
explained in terms of the two simultaneous equilibria that are taking place: 
complexation with CD, and TPGS micellization, both occurring on a different time-
scale. The lack of new signals in the spectrum of DIMEB at low DIMEB/TPGS ratios 
implies that the reaction in which the CD is involved (complexation) occurs at a fast 
exchange rate, leading to a shift in the resonances (such as H(3) and H(5)), rather than 
the appearance of new ones. In contrast, TPGS micellization must occur at a slower 
exchange rate compared to the NMR timescale, as reflected in the splitting of d and e 
protons. This (relatively) slower kinetics of micellization compared to the exchange 
rate of the surfactant in and out of the cyclodextrin confirms the fast micelle 
disruption process observed by TR-SANS. At higher DIMEB/TPGS molar ratios, 
there are no longer micelles, but only complexed monomers, which show a different 
 spectrum compared to the surfactant alone in water (Figure 7). A similar behavior has 
been observed in gemini cationic surfactants with different spacer groups55, and most 
recently in a ruthenium metallosurfactant56.  
The precise location of the macrocycle was further ascertained from 2D-
ROESY spectroscopy, which provides information of the interactions between 
protons that are spatially close, producing a NOE resonance (Figure 8). A clear cross 
peak between the cavity protons (H(3) and H(5)) with the CH3(a) of TPGS is detected 
(circle 1, Figure 8), which confirms that DIMEB is threading the hydrophobic part of 
TPGS. A NOE resonance is also observed between the internal protons of the CD and 
the CH2(b) of TPGS (circle 2, Figure 8). This cross peak is less intense than the 
former, as methylene groups are less bulky than CH3, implying a larger distance 
between these protons and the cavity protons of DIMEB (the CH3(a) can be 
distinguished from the CH2(b) by their different areas in the 1D spectrum). In addition, 
an intense NOE between the CH3(a) of TPGS and the protons at the primary rim of 
DIMEB, Me(6), is also detected (circle 3, Figure 8). These CD protons (21 in total) 
are at the narrower rim of the cavity, spatially close to the protuberant methyl groups 
of the tocopherol moiety, contributing to the relatively high intensity of this cross-
peak. It is worth noting that, although d and e protons (from the benzene ring of 
TPGS) undergo an important shift (Figure 8), along with corresponding changes in 
the fluorescence spectra in the presence of DIMEB (Figure 4), no cross-peak in the 
ROESY spectrum appears between these and the cavity protons (Figure 8). A possible 
explanation for this is that CH3(d) and CH3(e) are acting as a steric barrier that 
prevents further “hopping” of the CD beyond the benzene. A shallow inclusion of the 
aromatic ring, with a subsequent change in its micropolarity (when going from the 
micellar state to the complexed monomer) may account for the observed changes in 
the fluorescence spectra. 
The precise stoichiometry of the complex can also be obtained from NMR, 
using a Job’s plot. The signals from selected protons of DIMEB are plotted as a 
function of CD mole fraction, DIMEB (Figure 9). The curves all show a maximum 
which varies between 0.67 and 0.75, corresponding to a 2:1 or a 3:1 stoichiometry 
(CD:TPGS). A multivariable fit to H(3), H(5) and H(1) protons to a 2:1 consecutive 
equilibrium was attempted, but did not yield reliable values of K1 and K2, thus 
pointing to a 3:1 complex. A further estimation of the stoichiometry can also be 
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obtained by following the procedure based on the Hill’s equation, which also provides 
information on the cooperative nature of the complexation, and was recently applied 
to pseudopolyrotaxanes of poloxamines and DIMEB30. In brief, it consists in finding 
the concentration of free CD from NMR data, assuming that the chemical shift of a 
CD proton in the complex does not depend sensibly on the degree of threading, as the 
magnetic environments must be similar. Under this assumption, the fraction of 
binding sites of TPGS occupied by CD, θ, can be expressed as: 
 
 𝜃 =
[𝐶𝐷]ℎ
[𝐶𝐷]ℎ+𝐾𝑖
ℎ Eq.8 
where [CD] is the concentration of free host, Ki an average microscopic dissociation 
constant, and h is the Hill coefficient, describing the cooperativity of the binding. 
[CD] and θ were estimated from the protons of DIMEB whose resonances undergo 
the largest shifts and can thus be unambiguously tracked (H(1), H(3), H(5) and 
Me(6)), by averaging both variables calculated for each dataset (SI, Figure S8). 
Following this procedure, a value of 1.9  0.5 was obtained for h, indicating a rather 
positively cooperative process, in which the entrance of a macrocycle is favoured 
once a CD is already complexed. In addition, the saturation is reached at exactly n = 3, 
which confirms the 3:1 stoichiometry. The fitted average microscopic dissociation 
constant obtained is Ki = (1.30.2)10-4 mol·L-1, equivalent to a binding constant per 
equilibrium log Kb = 3.9, a value typical of 1:1 complexes of CDs with bulky 
aliphatic guests. For comparison, for the complex of poloxamine T904 with DIMEB, 
log Kb is lower, at 2.38
30, a consequence of propylene oxide being less bulky and 
hydrophobic than the hydrocarbon chain of tocopherol. It is worth noting that the 
Hill’s equation only has a semi-empirical character, and the binding constant reported 
above is not the actual intrinsic constant per site. In the case of equivalent binding 
sites, Hill’s equation reduces to the Langmuir one: 
 
 𝜃 =
[𝐶𝐷]𝑛
[𝐶𝐷]𝑛+𝐾𝑛
 Eq. 9 
 
where n is the number of sites (3 in this system), and K the global thermodynamic 
constant for the dissociation reaction, from which the actual intrinsic constant can be 
obtained by statistical considerations. By imposing the condition that the sites are 
 equivalent (h = 3 in Hill’s equation) we obtain a very similar K value of (1.2  
0.1)10-4 mol·L-1, suggesting that the cooperative effect is not very remarkable in this 
system. We refer the reader to reference 57 for a deeper understanding of this topic, 
which is sometimes overlooked in the scientific literature. 
 
SUMMARY AND CONCLUSIONS 
We have reported in this work a comprehensive structural investigation on the 
aggregation process of TPGS-1000 micelles, using scattering and spectroscopic 
methods. TPGS micelles form gradually, rather than showing the sharp aggregation 
onset typical of smaller surfactants. The micelles display a core-shell architecture with a 
core of ~ 38 Å and a largely hydrated PEO shell of ~ 28 Å. The micelles were 
remarkably insensitive to both concentration and temperature, a critical advantage in the 
application of this surfactant as a drug carrier. The impact that different cyclodextrins 
(CDs) have on the self-assembly of TPGS was studied, and show that not only the 
nature of the substituents, but also the substitution pattern (random, or regular) are 
critical in determining the outcome. Native CDs consistently lead to the precipitation of 
a polypseudorotaxane, resulting from the threading of the PEG and/or the tocopheryl 
moiety of TPGS by the macrocycle, as has been reported for PEO or PEO-based 
amphiphilic block-copolymers. DIMEB, a CD which is regularly dimethylated in 
positions 2 and 6, strongly disrupts the aggregation process, as consistently observed 
throughout our work with other amphiphilic macromolecules, while the thrice-
methylated equivalent (TRIMEB) has no detectable effect, and a randomly methylated 
CD (RAMEB) induces the formation of large, indiscriminate aggregates. Other 
randomly substituted CDs, like HPBCD or HEBCD, do not seem to modify the 
aggregation behavior of TPGS, which may be of interest for the combined use of this 
surfactant and CDs including a drug in the cavity, for example. 
Kinetic pathways of were explored by time-resolved SANS for the surfactant 
and DIMEB, revealing extremely fast kinetics of micelle disruption (< 100 ms, the limit 
of detection of the technique) and the formation of large aggregates, whose size and 
volume fraction evolve over time, alongside the TPGS-DIMEB complex which forms 
instantaneously. These large aggregates are not present at higher DIMEB/TPGS ratios. 
1H and ROESY NMR experiments demonstrate that DIMEB solubilizes TPGS by the 
incorporation of up to three macrocycles on the tocopheryl part of the molecule in a 
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rather cooperative process, in which the incorporation of a CD favors the subsequent 
threading of the aliphatic chain.  
Overall, the systematic study presented here provides detailed structural and 
mechanistic information on TPGS associative behavior, kinetic pathways and their 
modulation by cyclodextrins. This detailed understanding should help provide a solid 
basis for the design of multi-component drug delivery systems based on these two FDA-
approved, attractive pharmaceutical excipients. 
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Figure 1. a) Fluorescence emission spectra of TPGS up to 0.04%; b) Normalized intensity at 
max. 
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Figure 2. A. Intensity size distribution obtained by DLS at 20ºC from solutions of 1% TPGS 
alone (blue), and with the addition of 1% DIMEB (green) or 5% DIMEB (red); B. Intensity 
size distribution from a 1%TPGS solution with 5% RAMEB as a function of temperature. 
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Figure 3. SANS from 1% TPGS in D2O, alone and with 5% added DIMEB, at 20ºC and 
40ºC. 
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Figure 4. Excitation (A) and emission spectra (B) of 0.01% TPGS (blue) and with 3% 
DIMEB (red).  
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Figure 5. TR-SANS patterns for 1% TPGS with 3% DIMEB in D2O at selected time points 
(40°C). For comparison purposes, the scattering from 1% TPGS alone is also shown. 
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Figure 6. TR-SANS analysis of the kinetics of association between 1% TPGS and 3% 
DIMEB. The parameters shown result from modeling the scattering curves over a range of 
time points as a binary mixture of hard spheres (see text for details). A and B: Radius and 
volume fraction of the large aggregates; C and D: Radius and volume fraction of the TPGS-
CD complex.  
  
 
Figure 7. NMR spectra (aliphatic region) from mixtures of TPGS and DIMEB at varying 
ratios, expressed as TPGS mole fraction. 
 
Figure 8. 2D-ROESY spectrum of 1% TPGS solution with 2% DIMEB in D2O (DIMEB = 
0.69). 
29 
 
 
0.0 0.2 0.4 0.6 0.8 1.0
0.00
0.02
0.04
0.06
0.08
0.10
3:1
 
 

D
IM
E
B



DIMEB
 H(3)
 H(5)
 H(1)
 Me(2)
 Me(6)
2:1
 
Figure 9. Job’s plot for the complex between TPGS and DIMEB for selected protons of the 
cyclodextrin (Δδ is the difference in the chemical shift with respect to DIMEB alone). 
Vertical lines indicate the stoichiometry. 
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